Table: Sapporo Clinical Lab -2018/19 parent results

Sapporo Clinical Laboratory

13/05/2019 07:30

May 13 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           16.00           16.39          16.14         7.95    
               (-2.4 pct)      (+3.3 pct)     (+0.9 pct)    (+0.5 pct) 
  Operating      758 mln         963 mln                               
               (-21.3 pct)     (+31.3 pct)                             
  Recurring      757 mln         998 mln        780 mln      337 mln   
               (-24.1 pct)     (+30.6 pct)    (+3.0 pct)    (+9.6 pct) 
  Net            486 mln         649 mln        511 mln      220 mln   
               (-25.0 pct)     (+33.0 pct)    (+5.1 pct)   (+13.7 pct) 
  EPS          141.84 yen      186.80 yen     149.50 yen    64.32 yen  
  Ann Div       10.00 yen       11.00 yen      10.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       10.00 yen       11.00 yen      10.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T